50th Amendment to the IFRA Code of Practice
On June 30, IFRA announced the notification of the 50th Amendment to the IFRA Standards. The Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. The amendment introduced one update to the Standards and one new prohibited substance – Mintlacton.
Picture of Marta Pinto

Marta Pinto

Regulatory Affairs Associate

FRAGRANCES, IFRA CODE OF PRACTICE AND THE NEW AMENDMENT

Fragrances are complex mixtures of aromatic substances of natural and/or synthetic origin that are added to cosmetics and personal care products to impart a pleasant and distinctive odour, mask the inherent odour of some ingredients and/or enhance the user experience of the product. However, some fragrance ingredients may have the potential to cause allergic contact skin reactions (like dermal sensitization).

It is possible to analyse these substances using a methodology called Quantitative Risk Assessment (QRA) to determine safe use levels of fragrance ingredients in a variety of consumer product types. Organizations such as the International Fragrance Association (IFRA) and the Research Institute for Fragrance Materials (RIFM) use QRA to conduct safety assessments. The International Fragrance Association (IFRA) was founded in 1973 and represents the interests of the fragrance industry worldwide. The IFRA Code of Practice is essentially the “global fragrance industry’s commitment to promoting the safe use of fragrance for everyone’s enjoyment”. Fragrance compliance means following the rules of the IFRA Code of Practice and the IFRA Standards (see previous post).

IFRA Code of Practice includes the manufacture and handling of all fragrance materials, for all types of applications. IFRA Standards form the basis for the globally accepted and recognized risk management system for the safe use of fragrance ingredients and are part of the IFRA Code of Practice. These Standards limit or ban the usage of certain fragrance materials. IFRA gathers information regarding the safety of individual fragrance ingredients and reviews that information to determine their safety under expected conditions of product use. The conclusions of the IFRA safety reviews are published in the IFRA Code of Practice which provides critical guidance to fragrance formulators and cosmetic products manufacturers. New scientific developments about analysed substances often justify amendments to the Code and Standards.

On June 30 this year (2021), the notification of the 50th amendment to the IFRA Standards was issued. According to the notification, there is only one update to the Standards and one new prohibited substance (Mintlacton – CAS No. 13341-72-5). All other elements of the 49th Amendment addressing fragrance materials remain unchanged and in place. Timelines for implementation of the prohibition of use of Mintlacton were set as follows:

  • For new creations – 2 months after the date of the notification letter;
  • For existing creations – 13 months after the date of the notification letter.

The timelines set only apply to the supply of the fragrance mixtures, not to finished products.

Fragrance manufacturers and cosmetic companies have the responsibility to ensure that the fragrances used are safe and compliant with the IFRA Code of Practice and Standards. If you need further information or support on this subject, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. The International Fragrance Association (IFRA) – Notification of the 50th Amendment to the IFRA Standards. June 30, 2021.  
  3. The International Fragrance Association (IFRA) – Guidance for the use of IFRA Standards, 2019

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »